# US 2012/0252807 A1 · Arbovirus inhibitors and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252807 A1
- Document ID: US20120252807A1
- Status: Published application
- Kind: A1
- Application number: 13/423,647
- Filed: 2012-03-19
- Published: 2012-10-04
- Earliest claimed: 2011-03-31
- Assignees: The Regents of the University of Michigan
- Inventors: Scott Larsen; Janice Sindac; Scott Barraza; David J. Miller
- Web page: https://patentgrep.com/patent/US20120252807A1

## CPC

- C07D 401/06: linked by a carbon chain containing only aliphatic carbon atoms
- A61P 31/12: Antivirals
- A61P 31/14: for RNA viruses
- C07D 401/14: containing three or more hetero rings
- C07D 471/04: Ortho-condensed systems
- C07D 491/048: the oxygen-containing ring being five-membered
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides compounds as inhibitors of arboviruses.

## Claims

### Claim 1

A composition comprising a compound having the Formula I:
including pharmaceutically acceptable salts, prodrugs, and both R and S enantiomeric forms and racemic mixtures thereof;
wherein R1 is selected from the group consisting of H, a C1-C8 alkyl, a substituted C1-C8 alkyl, a C0-C6 alkyl-aryl, a substituted C0-C6 alkyl-aryl, or a C0-C6-alkyl-heteroaryl, and a substituted C0-C6-alkyl-heteroaryl;
wherein X and Y are either each H or each together form a fused phenyl ring substituted with R2;
wherein R2 is selected from the group consisting of H, halogen, OR3, NR3R4, NHC(═O)R3, NHSO2R3, C(═O)NR3R4, C1-C6 alkyl, C0-C6 alkyl-aryl and C0-C6-alkyl-heteroaryl;
wherein R3 and R4 are the same or different, and are selected from the group consisting of H, C1-C8 alkyl, C0-C6 alkyl-aryl, C0-C6 cycloalkyl-aryl, C0-C6-alkyl-heteroaryl, C0-C6-cycloalkyl-heteroaryl, or together form a substituted cyclic alkyl amine of 4-8 atoms or together form a piperazine ring substituted on the 4-nitrogen by CH2R5 or C(═O)R5; wherein alkyl, cycloalkyl, aryl and heteroaryl may be optionally substituted;
wherein R5 is C0-C6 alkyl-aryl or C0-C6-alkyl-heteroaryl;
wherein Z is selected from the group consisting of CH and N;
wherein G is selected from the group consisting of CH2-aryl, CH2-heteroaryl, C(═O)NR3R4, CH(OH)R3, and CH2NR3R4; and
wherein A is selected from the group consisting of CH, C—CH3 and N.

### Claim 2 (depends on 1)

The composition of claim 1, wherein R1 is selected from the group consisting of aryl, substituted aryl, heteroaryl and substituted heteroaryl.

### Claim 3 (depends on 2)

The composition of claim 2, wherein R1 is selected from the group consisting of
and.

### Claim 4 (depends on 3)

The composition of claim 3, wherein Z is CH and G is CONR3R4.

### Claim 5 (depends on 1)

The composition of claim 1, wherein G is selected from the group consisting of

### Claim 6 (depends on 1)

The composition of claim 1, wherein said compound is selected from the group consisting of

### Claim 7 (depends on 1)

A pharmaceutical composition, comprising:
a compound as recited in claim 1; and
b) a pharmaceutically acceptable carrier.

### Claim 8

A method of killing or preventing the growth of an arbovirus, comprising contacting an arbovirus with a compound under conditions such that said compound kills or prevents the growth of said arbovirus, wherein said compound is shown in Formula I:
including pharmaceutically acceptable salts, prodrugs, and both R and S enantiomeric forms and racemic mixtures thereof;
wherein R1 is selected from the group consisting of H, a C1-C8 alkyl, a substituted C1-C8 alkyl, a C0-C6 alkyl-aryl, a substituted C0-C6 alkyl-aryl, or a C0-C6-alkyl-heteroaryl, and a substituted C0-C6-alkyl-heteroaryl;
wherein X and Y are either each H or each together form a fused phenyl ring substituted with R2;
wherein R2 is selected from the group consisting of H, halogen, OR3, NR3R4, NHC(═O)R3, NHSO2R3, C(═O)NR3R4, C1-C6 alkyl, C0-C6 alkyl-aryl and C0-C6-alkyl-heteroaryl;
wherein R3 and R4 are the same or different, and are selected from the group consisting of H, C1-C8 alkyl, C0-C6 alkyl-aryl, a C0-C6-alkyl-heteroaryl, a substituted C0-C6-alkyl-heteroaryl, and together form a substituted cyclic alkyl amine of 4-8 atoms or together form a piperazine ring substituted on the 4-nitrogen by CH2R5 or C(═O)R5;
wherein R5 is C0-C6 alkyl-aryl or C0-C6-alkyl-heteroaryl
wherein Z is selected from the group consisting of CH and N;
wherein G is selected from the group consisting of CH2-aryl, CH2-heteroaryl, C(═O)NR3R4, CH(OH)R3, and CH2NR3R4; and
wherein A is selected from the group consisting of CH, C—CH3 and N.

### Claim 9 (depends on 8)

The method of claim 8, wherein R1 is selected from the group consisting of aryl, substituted aryl, heteroaryl and substituted heteroaryl.

### Claim 10 (depends on 9)

The method of claim 9, wherein R1 is selected from the group consisting of phenyl,

### Claim 11 (depends on 8)

The method of claim 8, wherein the compound is selected from the group consisting of

### Claim 12 (depends on 8)

The method of claim 8, wherein G is selected from the group consisting of

### Claim 13 (depends on 8)

The method of claim 8, wherein Z is CH and G is CONR3R4.

### Claim 14 (depends on 8)

The method of claim 8, wherein said compound is selected from the group consisting of

### Claim 16 (depends on 9)

The method of claim 9, wherein said arbovirus is in a cell.

### Claim 17 (depends on 16)

The method of claim 16, wherein said cell is in an animal.

### Claim 18 (depends on 17)

The method of claim 17, wherein said animal exhibits symptoms of an arbovirus infection and said contacting with said compound results in a decrease or elimination of said symptoms of an arbovirus infection.

### Claim 19 (depends on 9)

The method of claim 9, wherein said arbovirus is selected from the group consisting of an alphavirus, a flavivirus and a bunyavirus.

### Claim 20 (depends on 19)

The method of claim 19, wherein said alphavirus is selected from the group consisting of Sindbis virus, Semliki forest virus, O'nyong'nyong virus, Chikungunya virus, Mayaro virus, Ross River virus, Barmah Forest virus, Eastern equine encephalitis virus, Western equine encephalitis virus, and Venezuelan equine encephalitis virus.

### Claim 21 (depends on 19)

The method of claim 19, wherein said flavivirus is selected from the group consisting of West Nile virus, St. Louis encephalitis virus and Japanese encephalitis virus.

### Claim 22 (depends on 19)

The method of claim 19, wherein said bunyavirus is selected from the group consisting of La Crosse encephalitis virus and California encephalitis virus.
